Search results
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoCARsgen chief medical officer Raffaele Baffa said: “The preliminary results of the ongoing study...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 4 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 6 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell ...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 4 days agoFor many people, the treatment has been life-changing — however, as the first CAR T-cell therapy was...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 5 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important ...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 7 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR)